These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 37796763)
1. Structural, Functional, and Mutational Studies of a Potent Subtilisin Inhibitor from Budgett's Frog, Rami M; Shafique M; Sarma SP Biochemistry; 2023 Oct; 62(20):2952-2969. PubMed ID: 37796763 [TBL] [Abstract][Full Text] [Related]
2. NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition. Cabrera-Muñoz A; Valiente PA; Rojas L; Alonso-Del-Rivero Antigua M; Pires JR J Struct Biol; 2019 Jun; 206(3):280-294. PubMed ID: 30930219 [TBL] [Abstract][Full Text] [Related]
3. A Novel Trypsin Inhibitor-Like Cysteine-Rich Peptide from the Frog Lepidobatrachus laevis Containing Proteinase-Inhibiting Activity. Wang YW; Tan JM; Du CW; Luan N; Yan XW; Lai R; Lu QM Nat Prod Bioprospect; 2015 Aug; 5(4):209-14. PubMed ID: 26329591 [TBL] [Abstract][Full Text] [Related]
4. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. McPhalen CA; James MN Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813 [TBL] [Abstract][Full Text] [Related]
5. Structural basis of inhibition revealed by a 1:2 complex of the two-headed tomato inhibitor-II and subtilisin Carlsberg. Barrette-Ng IH; Ng KK; Cherney MM; Pearce G; Ryan CA; James MN J Biol Chem; 2003 Jun; 278(26):24062-71. PubMed ID: 12684499 [TBL] [Abstract][Full Text] [Related]
6. Structural basis for dual-inhibition mechanism of a non-classical Kazal-type serine protease inhibitor from horseshoe crab in complex with subtilisin. Shenoy RT; Thangamani S; Velazquez-Campoy A; Ho B; Ding JL; Sivaraman J PLoS One; 2011 Apr; 6(4):e18838. PubMed ID: 21541315 [TBL] [Abstract][Full Text] [Related]
7. Loss of second and sixth conserved cysteine residues from trypsin inhibitor-like cysteine-rich domain-type protease inhibitors in Bombyx mori may induce activity against microbial proteases. Li Y; Liu H; Zhu R; Xia Q; Zhao P Peptides; 2016 Dec; 86():13-23. PubMed ID: 27677962 [TBL] [Abstract][Full Text] [Related]
8. Budgett's frog (Lepidobatrachus laevis): A new amphibian embryo for developmental biology. Amin NM; Womble M; Ledon-Rettig C; Hull M; Dickinson A; Nascone-Yoder N Dev Biol; 2015 Sep; 405(2):291-303. PubMed ID: 26169245 [TBL] [Abstract][Full Text] [Related]
9. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. Bode W; Papamokos E; Musil D Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis of propeptide as an intramolecular chaperone for in vivo folding of subtilisin nattokinase. Jia Y; Liu H; Bao W; Weng M; Chen W; Cai Y; Zheng Z; Zou G FEBS Lett; 2010 Dec; 584(23):4789-96. PubMed ID: 21074529 [TBL] [Abstract][Full Text] [Related]
11. Amino Acid Substitutions at P1 Position Change the Inhibitory Activity and Specificity of Protease Inhibitors BmSPI38 and BmSPI39 from Li Y; Wei M; Zhang J; Zhu R; Wang Y; Zhang Z; Chen C; Zhao P Molecules; 2023 Feb; 28(5):. PubMed ID: 36903318 [TBL] [Abstract][Full Text] [Related]
12. Requirement for a disulfide bridge near the reactive site of protease inhibitor SSI (Streptomyces subtilisin inhibitor) for its inhibitory action. Kojima S; Kumagai I; Miura K J Mol Biol; 1993 Mar; 230(2):395-9. PubMed ID: 8464055 [TBL] [Abstract][Full Text] [Related]
13. Phylogenetic analyses reveal molecular signatures associated with functional divergence among Subtilisin like Serine Proteases are linked to lifestyle transitions in Hypocreales. Varshney D; Jaiswar A; Adholeya A; Prasad P BMC Evol Biol; 2016 Oct; 16(1):220. PubMed ID: 27756202 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of subtilisin DY, a random mutant of subtilisin Carlsberg. Eschenburg S; Genov N; Peters K; Fittkau S; Stoeva S; Wilson KS; Betzel C Eur J Biochem; 1998 Oct; 257(2):309-18. PubMed ID: 9826175 [TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases. Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148 [TBL] [Abstract][Full Text] [Related]
16. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism. Longstaff C; Campbell AF; Fersht AR Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109 [TBL] [Abstract][Full Text] [Related]
17. Homology modelling and protein engineering strategy of subtilases, the family of subtilisin-like serine proteinases. Siezen RJ; de Vos WM; Leunissen JA; Dijkstra BW Protein Eng; 1991 Oct; 4(7):719-37. PubMed ID: 1798697 [TBL] [Abstract][Full Text] [Related]
18. Refined 1.2 A crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin. Bode W; Papamokos E; Musil D; Seemueller U; Fritz H EMBO J; 1986 Apr; 5(4):813-8. PubMed ID: 3519213 [TBL] [Abstract][Full Text] [Related]
19. Primary structure and inhibitory properties of a subtilisin-chymotrypsin inhibitor from Streptomyces virginiae. Terabe M; Kojima S; Taguchi S; Momose H; Miura K Eur J Biochem; 1994 Dec; 226(2):627-32. PubMed ID: 8001578 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of an intracellular subtilisin reveals novel structural features unique to this subtilisin family. Vévodová J; Gamble M; Künze G; Ariza A; Dodson E; Jones DD; Wilson KS Structure; 2010 Jun; 18(6):744-55. PubMed ID: 20541512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]